WEBSITECHANGES

Website Changes

---

05/02/2024

Brain Tumor Awareness Month Webinar Series

---

04/29/2024

Path forward for glioblastoma treatment

---

04/29/2024

Brain Tumor Awareness Month Webinar Series

---

04/29/2024

New York Advocacy Alert!

---

04/28/2024

Results from a first-in-human phase I safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma

---

04/28/2024

FDA approves new drug for pediatric low-grade glioma with BRAF fusions or mutation

---

04/22/2024

Carthera partners with Agenus and Northwestern University for phase 2a trial combining SonoCloud-9 with checkpoint inhibitors to treat glioblastoma

---

04/22/2024

Urgent funding needed for DIPG sonodynamic therapy trial

---

04/22/2024

Gene Therapy Is Halting Cancer - Can It Work Against Brain Tumors?

---

04/22/2024

ROSALIE Trial of EO2401/Nivolumab/Bevacizumab in Recurrent Glioblastoma Concludes

---

04/15/2024

Ivy Brain Tumor Center Announces Promising Results of Phase 0/1 Glioblastoma Study at AACR Annual Meeting

---

04/15/2024

Upcoming Musella Foundation May Webinars!

---

04/15/2024

UCLA Brain Tumor Center to Host 24th Annual UCLA Brain Tumor Conference

---

04/15/2024

`The Brain Surgeon`s Take` podcast episode with Dr. Al Musella on the Promising Pathway Act

---

04/11/2024

Evaluation of the EMulate Therapeutics Voyager`s ultra-low radiofrequency energy in murine model of glioblastoma

---

04/08/2024

Real-world cost-effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China

---

04/05/2024

Sex differences in adverse events in Medicare individuals > 66 years of age post glioblastoma treatment

---

04/03/2024

Tumor Takedown Fundraiser: Cape Coral, FL May 4, 2024

---

04/01/2024

Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and Temozolomide

---

04/01/2024

Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma

---

03/30/2024

Low-Grade Glioma Webinar TOMORROW

---

03/29/2024

Prolonged use of certain hormone drugs linked to increased brain tumor risk

---

03/29/2024

Advocacy Alert for Washington Residents! Comment publicly to support Washington State HCA coverage of Tumor Treating Fields

---

03/28/2024

METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer

---

03/28/2024

First Participant Receives Sonodynamic Therapy for Glioblastoma in New Clinical Trial

---